Real-life studies in allergen immunotherapy

被引:12
|
作者
Passalacqua, Giovanni [1 ]
Bagnasco, Diego [1 ]
机构
[1] Univ Genoa, Allergy & Resp Dis, IRCCS Policlin San Martino, Lgo R Benzi 10, I-16133 Genoa, Italy
关键词
allergen immunotherapy; efficacy; real life; real world; safety; RANDOMIZED CONTROLLED-TRIALS; ADVERSE SYSTEMIC REACTIONS; SUBLINGUAL IMMUNOTHERAPY; EUROPEAN SURVEY; ASTHMA; RHINITIS; SAFETY; MANAGEMENT; EFFICACY; EASSI;
D O I
10.1097/ACI.0000000000000757
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Real-life (or real-world) studies can provide information that cannot be derived from randomized controlled trials. This approach is currently becoming of relevance for many treatments. In recent years, the real-life method has been applied also to allergen immunotherapy, providing new insights on it. We reviewed herein the available literature on the argument. Recent findings Several prospective and retrospective studies on allergen immunotherapy in the real-world setting have been published, mostly in the last 5 years. Most of them focused on adverse events, compliance, and the long term/preventive effects, and evidenced an overall favorable profile for different products and different allergens. Real life study provided novel information and evidenced those aspects of immunotherapy that worth a more detailed approach, without the strict limitations usually imposed by controlled randomized trials.
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [41] Retrospective Cohort Study on the Impact of Immunotherapy with depigmented, polymerized Allergen Extract on the Occurrence and Progression of atopic Dermatitis (AD) under Real-life Conditions
    Mueller, T.
    Nemat, K.
    Richter, H.
    Sager, A.
    ALLERGOLOGIE, 2022, 45 (08) : 621 - 621
  • [42] Characteristics of Adverse Reactions and Compliance in Patients who Underwent Allergen-Specific Subcutaneous Immunotherapy; Ten-Year Real-Life Data
    Baccioglu, Ayse
    Kalpaklioglu, Ayse Fusun
    Poyraz, Merve
    Alan Yalim, Sumeyra
    Dumanoglu, Betul
    Alpagat, Gulistan
    ASTIM ALLERJI IMMUNOLOJI, 2022, 20 (01): : 6 - 15
  • [43] Does a clinical study reflect real-life and real-life costs
    Juhl, HH
    Hvenegaard, A
    Schmidt, VM
    Habicht, A
    VALUE IN HEALTH, 2005, 8 (03) : 373 - 374
  • [44] Real-life evidence in allergen immuno-therapy: Moving forward with mHealth apps
    Sousa-Pinto, B.
    Pfaar, O.
    Bousquet, J.
    ALLERGOLOGIE, 2023, 46 (03) : 193 - 203
  • [45] Do threshold data from food challenges reflect real-life allergen exposure?
    Garcia, Alvarez O.
    Bartra, J.
    Garcia, Ruiz M.
    Skypala, I
    Durham, S.
    Boyle, R. J.
    Mills, C.
    Turner, P. J.
    ALLERGY, 2019, 74 : 151 - 151
  • [46] Lung cancer and immunotherapy: a real-life experience from second line and beyond
    El Karak, Fady
    Haddad, Fady Gh
    Eid, Roland
    Al Ghor, Maya
    El Rassy, Elie
    Ahmadieh, Nizar
    Choullamy, Theresia
    Halim, Nour A.
    Tfayli, Arafat
    Farhat, Fadi
    Kattan, Joseph
    Nasr, Fady
    Ghosn, Marwan
    Assi, Hazem, I
    FUTURE ONCOLOGY, 2019, 15 (26) : 3025 - 3032
  • [47] Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
    Ilie, Mirela Diana
    Villa, Chiara
    Cuny, Thomas
    Cortet, Christine
    Assie, Guillaume
    Baussart, Bertrand
    Cancel, Mathilde
    Chanson, Philippe
    Decoudier, Benedicte
    Deluche, Elise
    Di Stefano, Anna Luisa
    Drui, Delphine
    Gaillard, Stephan
    Goichot, Bernard
    Huillard, Olivier
    Joncour, Anthony
    Larrieu-Ciron, Delphine
    Libe, Rossella
    Nars, Guillaume
    Vasiljevic, Alexandre
    Raverot, Gerald
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (05) : 685 - 696
  • [48] Safety of subcutaneous and sublingual immunotherapy with allergoids in children: a real-life pharmacovigilance study
    Frati, Franco
    De Beni, Noemi
    Marastoni, Laura
    Compalati, Enrico
    Ciprandi, Giorgio
    IMMUNOTHERAPY, 2024, 16 (01) : 43 - 53
  • [49] Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience
    Asher, Nethanel
    Israeli-Weller, Noa
    Shapira-Frommer, Ronnie
    Ben-Betzalel, Guy
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2021, 13 (12)
  • [50] Cup A1 Precision Immunotherapy: A First Safety Real-Life Stud
    Bernal Rubio, L.
    Valbuena Garrido, M. T.
    Bernaola Abraira, M.
    Roger Reig, A.
    De Las Heras Gozalo, M.
    Cimarra ALvarez, M.
    Ojeda Fernandez, P.
    San Andres, F.
    Dalmau Duch, G.
    Lopez Couso, V.
    ALLERGY, 2023, 78